IBS and rosacea in adults: how common is rosacea among people with IBS at a university center

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a real-world, observational analysis conducted at IRCCS AOU Policlinico di Sant'Orsola in Bologna. The study examines the prevalence and clinical features of rosacea among patients with confirmed IBS seen in internal medicine, digestive physiopathology, and dermatology outpatient clinics within the last year. By describing co-occurrence in an Italian tertiary-care setting, the study aims to contribute data on the gut-skin axis in routine clinical practice. No experimental interventions are planned; data will be analyzed retrospectively from medical records. The findings may help characterize patient characteristics and inform future research on shared mechanisms between the gut and skin.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Evaluation at the Internal Medicine, Digestive Physiopathology, and Dermatology outpatient clinics of the IRCCS AOU Policlinico di Sant'Orsola in Bologna within the last 12 months.
* Presence of a confirmed diagnosis of IBS and/or rosacea documented in the outpatient medical record.
* Availability of clinical data essential for the analysis.

Exclusion Criteria:

* Age \<18 years.
* Unable to confirm the presence of IBS and/or rosacea.
* Insufficient clinical data for analysis.

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy, Italy Recruiting

Study contacts

• Principal investigator: Giovanni Barbara, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Giovanni Barbara, MD
• Email: giovanni.barbara@unibo.it
• Phone: 0512144103

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Probiotic in IBS-D and functional diarrhea (three-month test)

  A probiotic capsule is being tested to see if it can improve symptoms and quality of life for adults with diarrhea-predominant IBS or functional diarrhea compared with a placebo.

  Recruiting Szeged University · Szeged · NCT07916688

• UCB8600 and mast cell activation in the gut for IBS

  This study tests whether UCB8600 can reduce mast cell activation in the gut to help people with IBS.

  Recruiting KU Leuven · Leuven, Vlaams-Brabant · NCT07655375

• Transcutaneous Auricular Vagus Nerve Stimulation for Rosacea

  A small, single-arm pilot study will test whether taVNS can help adults with rosacea and moderate flushing or redness.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07600424

• Regular enzyme blend to help bloating in adults with IBS and similar symptoms

  This study tests whether a FODMAP-targeting digestive enzyme blend (taken with meals) reduces bloating and related gut symptoms compared with placebo in adults who self-report bloating.

  Recruiting Kiwi Health Inc · Los Angeles, California · NCT07591584

• Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease

  This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.

  Recruiting at 2 sites University of Palermo · Palermo, PA and 1 other locations · NCT07584473

• Variable Compression System for moderate to severe IBS

  This pilot will try a wearable Variable Compression System device for adults with moderate to severe IBS to see if wearing it reduces symptoms and is safe.

  Recruiting at 3 sites PGP Health · Kissimmee, Florida and 2 other locations · NCT07540312

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.